Nippon India Pharma Fund - Direct (G) vs Tata Small Cap Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs Tata Small Cap Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

7.4%

stock2

Tata Small Cap Fund - Direct (G)

-4.88%

Loading chart...

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Deutsche Bank HDFC CitiBank N.A. Standard Chartered Bank

CAMS Ltd. Karvy Computershare P Ltd MCS Ltd.

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

Very High Risk

5000

12528.86

1.77

43.2517

October 19, 2018

0

14.01 %

19.35 %

7.4 %

15.63 %

12.82 %

-4.88 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Chandraprakash Padiyar

MBA (Finance), cleared all 3 levels of CFA Program from The CFA Institute, USA

Brief Experiance (10 year) From April 2007 to August 2018 with Alchemy Capital Management Pvt Ltd. where he was 'Director & Portfolio Manager' for their omshore long only strategies. Reporting to Chief Investment Officer.

Get your FAQs right